Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)

Drug and Alcohol Dependence

Volumn 101, Issue 3, 2009, Pages 152-157

  Evans, Jennifer L ^a   Hahn, Judith A ^a   Lum, Paula J ^a   Stein, Ellen S ^a   Page, Kimberly ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cessation; Injection drug use; Relapse; Youth

Indexed keywords

BENZODIAZEPINE; DIAMORPHINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RELAPSE; SURVIVAL; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HOMELESS PERSONS; HUMANS; INTERVIEWS AS TOPIC; MALE; NEEDLE-EXCHANGE PROGRAMS; PRISONS; RECURRENCE; SAN FRANCISCO; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 61849112793     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.12.007     Document Type: Article

References (34)

1. Aceijas C., Stimson G.V., Hickman M., and Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. Aids 18 (2004) 2295-2303
2. Alter M.J. Prevention of spread of hepatitis C. Hepatology 36 (2002) S93-98
3. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J. Publ. Health (Oxf.) 27 (2005) 281-291
4. Bruneau J., Brogly S.B., Tyndall M.W., Lamothe F., and Franco E.L. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 99 (2004) 727-737
5. Clark W. Plenary session-SBIRT: adolescents and transition age youth. Substance abuse: current trends, current solutions. 32nd Annual National Conference of the Association for Medical Education and Research in Substance Abuse. Washington, DC (2008)
6. Compton W.M., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 81 (2006) 103-107
7. Darke S. The use of benzodiazepines among injecting drug users. Drug Alcohol Rev. 13 (1994) 63-69
8. Darke S., Hall W., Ross M., and Wodak A. Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug Alcohol Depend. 31 (1992) 31-36
9. Doherty M.C., Garfein R.S., Monterroso E., Brown D., and Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. Aids 14 (2000) 717-726
10. Dore G.J., Law M., MacDonald M., and Kaldor J.M. Epidemiology of hepatitis C virus infection in Australia. J. Clin. Virol. 26 (2003) 171-184
11. Fry C.L., and Bruno R.B. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. Drug Alcohol Rev. 21 (2002) 363-367
12. Galai N., Safaeian M., Vlahov D., Bolotin A., and Celentano D.D. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants. Am. J. Epidemiol. 158 (2003) 695-704
13. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1 (1998) S11-19
14. Goldstein M.F., Deren S., Magura S., Kayman D.J., Beardsley M., and Tortu S. Cessation of drug use: impact of time in treatment. J. Psychoactive Drugs 32 (2000) 305-310
15. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., and Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 186 (2002) 1558-1564
16. Henderson L.A., Vlahov D., Celentano D.D., and Strathdee S.A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J. Acquir. Immune Defic. Syndr. 32 (2003) 229-237
17. Joe G.W., Simpson D.D., and Hubbard R.L. Treatment predictors of tenure in methadone maintenance. J. Subst. Abuse 3 (1991) 73-84
18. Kittikraisak W., Davidson P.J., Hahn J.A., Lum P.J., Evans J.L., Moss A.R., and Page-Shafer K. Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection. J. Subst. Use 11 (2006) 271-281
19. Langendam M.W., van Brussel G.H., Coutinho R.A., and van Ameijden E.J. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction 95 (2000) 591-600
20. Latkin C.A., Knowlton A.R., Hoover D., and Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am. J. Drug Alcohol Abuse 25 (1999) 463-473
21. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., Wodak A., Panda S., Tyndall M., Toufik A., and Mattick R.P. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 372
22. Murphy D.A., Brecht M.L., Herbeck D., Evans E., Huang D., and Hser Y.I. Longitudinal HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample. Eval. Rev. 32 (2008) 83-112
23. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction, 1998. Effective medical treatment of opiate addiction. JAMA 280, 1936-1943.
24. National Institute on Drug Abuse, 2000. Hepatitis C Community Drug Alert Bulletin. Available: http://www.drugabuse.gov/HepatitisAlert/HepatitisAlert.html (accessed 10.17.08).
25. Office of National Drug Control Policy, 2004. The Economic Costs of Drug Abuse in the United States, 1992-2002. Executive Office of the President, Washington, DC (Publication No. 207303).
26. Schutz C.G., Rapiti E., Vlahov D., and Anthony J.C. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 36 (1994) 129-138
27. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., and Strathdee S.A. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. Aids 14 (2000) 2035-2043
28. Shah N.G., Galai N., Celentano D.D., Vlahov D., and Strathdee S.A. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend. 83 (2006) 147-156
29. Siegal H.A., Carlson R.G., Kenne D.R., and Swora M.G. Probable relationship between opioid abuse and heroin use. Am. Fam. Physician 67 (2003) 942, 945
30. Steensma C., Boivin J.F., Blais L., and Roy E. Cessation of injecting drug use among street-based youth. J. Urban Health 82 (2005) 622-637
31. Substance Abuse and Mental Health Services Administration, 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rep. No. NSDUH Series H-34. DHHS Publication No. SMA 08-4343. Rockville, MD.
32. van Ameijden E.J., and Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J. Epidemiol. Commun. Health 55 (2001) 356-363
33. Warner L.A., Alegria M., and Canino G. Remission from drug dependence symptoms and drug use cessation among women drug users in Puerto Rico. Arch. Gen. Psychiatry 61 (2004) 1034-1041
34. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., Patkar A., Publicker M., McCain K., Potter J.S., Forman R., Vetter V., McNicholas L., Blaine J., Lynch K.G., and Fudala P. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 300 (2008) 2003-2011